Compugen CGEN
NASDAQ CGEN
$2.59 +0.03 (+1.17%)
As of: Sep 4, 2026 · 3:19 PM EDT

Compugen (CGEN) Long-Term Investments (2009 - 2015)

Compugen (CGEN) posted quarterly Long-Term Investments of $3.7 million for Q1 2026, up 29.86% year-over-year from $2.9 million in Q1 2025, and up 2.31% on a QoQ basis from $3.6 million in Q4 2025.

Analysis

Compugen (CGEN) Long-Term Investments (2009 - 2015) Analysis & Trends

Compugen has reported Long-Term Investments for 18 years, with the latest figure at $3.7 million in Q1 2026.

  • Long-Term Investments for Q1 2026 came in at $3.7 million, up 29.86% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.7 million (up 29.86% YoY), and the FY2025 annual result was $3.6 million, up 18.59% from the prior year.
  • Long-Term Investments rose to $3.7 million in Q1 2026, from $3.6 million in the prior quarter.
  • Over five years, Long-Term Investments peaked at $3.7 million in Q1 2026 and troughed at $2.8 million in Q1 2023.
  • A 5-year average of $3.1 million and a median of $3.0 million in 2024 frame the typical range for Long-Term Investments.
  • The widest annual swing landed in 2023, when Long-Term Investments decreased 11.19%; it then rose 29.86% in 2026.
  • A 5-year view of Long-Term Investments shows it stood at $2.8 million in 2022, then advanced by 6.55% to $3.0 million in 2023, then advanced by 3.19% to $3.1 million in 2024, then rose by 18.59% to $3.6 million in 2025, then advanced by 2.31% to $3.7 million in 2026.
  • Per Business Quant data, the three most recent Long-Term Investments figures were $3.7 million in Q1 2026, $3.6 million in Q4 2025, and $3.4 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Vertex Pharmaceuticals 138.43 Bn 130.58 Bn 2.84 Bn 5.79 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 9.83 Bn
3 Argenx Se 63.34 Bn 58.15 Bn 1.37 Bn -4.00 Mn
4 Moderna 57.98 Bn 52.85 Bn 52.00 Mn 1.77 Bn
5 Revolution Medicines 43.98 Bn 43.98 Bn - -
6 BeOne Medicines 39.92 Bn 34.82 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.42 Bn 32.11 Bn 992.69 Mn 22.17 Mn
8 Royalty Pharma 28.42 Bn 27.58 Bn - 372.10 Mn
9 Insmed 27.36 Bn 26.20 Bn 358.27 Mn -
10 Compugen 241.50 Mn 155.89 Mn -92,000.00 -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2015 15.01 Mn
Mar 31, 2015 2.01 Mn
Dec 31, 2014 35.03 Mn
Sep 30, 2014 2.08 Mn
Jun 30, 2014 2.26 Mn
Mar 31, 2014 2.16 Mn
Dec 31, 2013 2.13 Mn
Sep 30, 2013 2.01 Mn
Jun 30, 2013 1.92 Mn
Mar 31, 2013 1.88 Mn
Dec 31, 2012 1.73 Mn
Sep 30, 2012 5.89 Mn
Jun 30, 2012 6.26 Mn
Mar 31, 2012 6.27 Mn
Dec 31, 2011 5.58 Mn
Sep 30, 2011 5.69 Mn
Jun 30, 2011 6.57 Mn
Mar 31, 2011 7.40 Mn
Dec 31, 2010 7.80 Mn
Sep 30, 2010 6.76 Mn